Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 41.3 -1.07 (-2.53%) Market Cap: 2.02 Bil Enterprise Value: 2.41 Bil PE Ratio: 14.29 PB Ratio: 3.00 GF Score: 77/100

Q2 2021 Amphastar Pharmaceuticals Inc Earnings Call Transcript

Aug 09, 2021 / 09:00PM GMT
Release Date Price: $20.08 (-1.13%)
Operator

Greetings, and welcome to the Amphastar Pharmaceuticals' Second Quarter Earnings Call. (Operator Instructions)

All statements in this press release and in the conference call referenced above that are not historical are forward-looking statements, including, among other things, statements relating to our expectations regarding future financial performance, backlog, sales and marketing of our products, market size and growth, product development, the timing of FDA filings or approvals, including the DMFs of ANP, the timing of product launches, acquisitions and other matters related to our pipeline of product candidates. Our share buyback program and other future events, such as the impact of COVID-19 pandemic, including its variance and related responses of business and governments to the pandemic on our operations and personnel and on commercial activity and demand across our business operations and results of operations. These statements are not facts, but rather are based on Amphastar's historical performance and our current expectations, estimates and projections regarding our business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot